Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Smith, , Timothy,
DOB:	10-SEP-1941 (Age: 84)
Gender:	male
Address:	9 Jeffrey orchard NW1 North Joshuaville (United Kingdom)
ID:	8029-862360-6 (ECI)

Report
Date:	11-DEC-2017

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Evelina Children's Hospital SE1 7 London (United Kingdom)

Specimen
Collected:	11-DEC-2017

Chemistry

Test	11-DEC-2017	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.5	4.5 - 6.4	%
Glucose [Mass/volume] in Blood	139.2	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	19.8	7 - 25	mg/dL
Creatinine [Mass/volume] in Blood	0.9	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	138.4	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.2 H	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	105.2	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	24.3	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	258.6 H	0 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	434.8 H	0 - 199	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	151.3 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	20.4 L	40 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	8.7	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows dyslipidemia with elevated total cholesterol, LDL, and triglycerides, and low HDL, increasing cardiovascular risk. Potassium is mildly elevated; monitor for possible renal or medication-related causes. Glucose and HbA1c are within normal limits, and renal function (urea, creatinine, microalbumin/creatinine) is preserved. No acute metabolic derangements detected. Recommend addressing lipid abnormalities and monitoring potassium.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows dyslipidemia with elevated total cholesterol, LDL, and triglycerides, and low HDL, increasing cardiovascular risk. Potassium is mildly elevated; monitor for possible renal or medication-related causes. Glucose and HbA1c are within normal limits, and renal function (urea, creatinine, microalbumin/creatinine) is preserved. No acute metabolic derangements detected. Recommend addressing lipid abnormalities and monitoring potassium.